|
Apr 5
|
China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz
|
|
Apr 5
|
2 Dividend Stocks to Buy Hand Over Fist in April
|
|
Apr 5
|
From Ray-Bans to Wigs, US Buyers May See Unexpected Price Hikes
|
|
Apr 3
|
AbbVie (ABBV) Stock Moves -1.73%: What You Should Know
|
|
Apr 3
|
AbbVie cuts 2025 profit forecast on acquisition expenses
|
|
Apr 3
|
3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About
|
|
Apr 2
|
AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?
|
|
Apr 1
|
High Growth Tech Stocks To Watch In The US April 2025
|
|
Mar 31
|
MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…
|
|
Mar 31
|
AbbVie to Host First-Quarter 2025 Earnings Conference Call
|
|
Mar 31
|
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
|
|
Mar 30
|
AbbVie Inc. (ABBV): Among the Best Dividend Aristocrat Stocks with Over 3% Yield
|
|
Mar 16
|
1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction
|
|
Mar 16
|
AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer
|
|
Mar 15
|
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
|
|
Mar 14
|
Top Analyst Reports for AbbVie, Lockheed Martin & Dell
|
|
Mar 14
|
Q4 2024 Regenxbio Inc Earnings Call
|
|
Mar 14
|
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
|
|
Mar 14
|
Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
|
|
Mar 12
|
Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds
|